{"id":"https://openalex.org/W2332344516","doi":"https://doi.org/10.1016/j.autrev.2016.03.018","title":"IVIG in autoimmune disease \u2014 Potential next generation biologics","display_name":"IVIG in autoimmune disease \u2014 Potential next generation biologics","publication_year":2016,"publication_date":"2016-03-24","ids":{"openalex":"https://openalex.org/W2332344516","doi":"https://doi.org/10.1016/j.autrev.2016.03.018","mag":"2332344516","pmid":"https://pubmed.ncbi.nlm.nih.gov/27019051"},"language":"en","primary_location":{"id":"doi:10.1016/j.autrev.2016.03.018","doi":"https://doi.org/10.1016/j.autrev.2016.03.018","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.autrev.2016.03.018","pdf_url":null,"source":{"id":"https://openalex.org/S12874817","display_name":"Autoimmunity Reviews","issn_l":"1568-9972","issn":["1568-9972","1873-0183"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Autoimmunity Reviews","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5064956979","display_name":"Adrian W. Zuercher","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I62612085","display_name":"CSL (Switzerland)","ror":"https://ror.org/01400tq86","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210153402","https://openalex.org/I62612085"]}],"countries":["CH"],"is_corresponding":true,"raw_author_name":"Adrian W. Zuercher","raw_affiliation_strings":["CSL Behring AG, Research, Switzerland. Electronic address: adrian.zuercher@cslbehring.com","CSL Behring AG, Research, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CSL Behring AG, Research, Switzerland. Electronic address: adrian.zuercher@cslbehring.com","institution_ids":["https://openalex.org/I62612085"]},{"raw_affiliation_string":"CSL Behring AG, Research, Switzerland","institution_ids":["https://openalex.org/I62612085"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061181578","display_name":"Rolf Spirig","orcid":"https://orcid.org/0000-0002-0304-8726","observed_orcids":["https://orcid.org/0000-0002-0304-8726"]},"institutions":[{"id":"https://openalex.org/I62612085","display_name":"CSL (Switzerland)","ror":"https://ror.org/01400tq86","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210153402","https://openalex.org/I62612085"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Rolf Spirig","raw_affiliation_strings":["CSL Behring AG, Research, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CSL Behring AG, Research, Switzerland","institution_ids":["https://openalex.org/I62612085"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076105158","display_name":"Adriana Baz Morelli","orcid":"https://orcid.org/0000-0002-5172-8849","observed_orcids":["https://orcid.org/0000-0002-5172-8849"]},"institutions":[{"id":"https://openalex.org/I4210153402","display_name":"CSL (Australia)","ror":"https://ror.org/044tc0x05","country_code":"AU","type":"company","lineage":["https://openalex.org/I4210153402"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Adriana Baz Morelli","raw_affiliation_strings":["CSL Ltd, Research, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CSL Ltd, Research, Australia","institution_ids":["https://openalex.org/I4210153402"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5085362965","display_name":"Fabian K\u00e4sermann","orcid":"https://orcid.org/0000-0002-4255-9350","observed_orcids":["https://orcid.org/0000-0002-4255-9350"]},"institutions":[{"id":"https://openalex.org/I62612085","display_name":"CSL (Switzerland)","ror":"https://ror.org/01400tq86","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210153402","https://openalex.org/I62612085"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Fabian K\u00e4sermann","raw_affiliation_strings":["CSL Behring AG, Research, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CSL Behring AG, Research, Switzerland","institution_ids":["https://openalex.org/I62612085"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5064956979"],"corresponding_institution_ids":["https://openalex.org/I62612085"],"apc_list":{"value":4730,"currency":"USD","value_usd":4730},"apc_paid":null,"fwci":1.138,"has_fulltext":false,"cited_by_count":65,"citation_normalized_percentile":{"value":0.73977695,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"15","issue":"8","first_page":"781","last_page":"785"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9868000149726868,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9868000149726868,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11725","display_name":"Immunodeficiency and Autoimmune Disorders","score":0.008299999870359898,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/intravenous-immunoglobulin","display_name":"intravenous immunoglobulin","score":0.996999979019165},{"id":"https://openalex.org/keywords/autoimmune-disease","display_name":"autoimmune disease","score":0.6710000038146973},{"id":"https://openalex.org/keywords/fc-region","display_name":"Fc fragment","score":0.7020000219345093},{"id":"https://openalex.org/keywords/fc-gamma-receptor","display_name":"Fc gamma receptor","score":0.7670000195503235},{"id":"https://openalex.org/keywords/fcrn","display_name":"neonatal Fc receptor","score":0.9789999723434448},{"id":"https://openalex.org/keywords/immunodeficiency","display_name":"immunodeficiency","score":0.5099999904632568},{"id":"https://openalex.org/keywords/gene-therapy","display_name":"gene therapy","score":0.5350000262260437},{"id":"https://openalex.org/keywords/recombinant-immunoglobulin","display_name":"recombinant immunoglobulin","score":0.7039999961853027},{"id":"https://openalex.org/keywords/immune-thrombocytopenic-purpura","display_name":"idiopathic thrombocytopenic purpura","score":0.7559999823570251},{"id":"https://openalex.org/keywords/kawasaki-disease","display_name":"Kawasaki disease","score":0.9850000143051147},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.6970000267028809}],"concepts":[{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.6863529682159424},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.6222712993621826},{"id":"https://openalex.org/C2780130043","wikidata":"https://www.wikidata.org/wiki/Q192360","display_name":"Autoimmunity","level":3,"score":0.5667649507522583},{"id":"https://openalex.org/C2780649865","wikidata":"https://www.wikidata.org/wiki/Q21101413","display_name":"Neonatal Fc receptor","level":4,"score":0.541535496711731},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.5238059759140015},{"id":"https://openalex.org/C125823703","wikidata":"https://www.wikidata.org/wiki/Q1616930","display_name":"Fragment crystallizable region","level":3,"score":0.5201616287231445},{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.5119191408157349},{"id":"https://openalex.org/C956191","wikidata":"https://www.wikidata.org/wiki/Q930144","display_name":"Polyclonal antibodies","level":3,"score":0.4668453633785248},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.4535440504550934},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4412257671356201},{"id":"https://openalex.org/C111599444","wikidata":"https://www.wikidata.org/wiki/Q213901","display_name":"Genetic enhancement","level":3,"score":0.43786129355430603},{"id":"https://openalex.org/C179223381","wikidata":"https://www.wikidata.org/wiki/Q419425","display_name":"Avidity","level":3,"score":0.4363834857940674},{"id":"https://openalex.org/C2779931124","wikidata":"https://www.wikidata.org/wiki/Q417823","display_name":"Fc receptor","level":3,"score":0.4323465824127197},{"id":"https://openalex.org/C2779019163","wikidata":"https://www.wikidata.org/wiki/Q3043160","display_name":"Primary immunodeficiency","level":3,"score":0.42138323187828064},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.41733479499816895},{"id":"https://openalex.org/C2780898057","wikidata":"https://www.wikidata.org/wiki/Q79448","display_name":"Immunoglobulin G","level":3,"score":0.3625287413597107},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3363415002822876},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.30212920904159546},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.2319433093070984},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.10450273752212524},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001688","descriptor_name":"Biological Products","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D001688","descriptor_name":"Biological Products","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007136","descriptor_name":"Immunoglobulins","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007136","descriptor_name":"Immunoglobulins","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007136","descriptor_name":"Immunoglobulins","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007141","descriptor_name":"Immunoglobulin Fc Fragments","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D007153","descriptor_name":"Immunologic Deficiency Syndromes","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D007153","descriptor_name":"Immunologic Deficiency Syndromes","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D007153","descriptor_name":"Immunologic Deficiency Syndromes","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false},{"descriptor_ui":"D007249","descriptor_name":"Inflammation","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D007279","descriptor_name":"Injections, Subcutaneous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011961","descriptor_name":"Receptors, Fc","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D015316","descriptor_name":"Genetic Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016756","descriptor_name":"Immunoglobulins, Intravenous","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D016756","descriptor_name":"Immunoglobulins, Intravenous","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.autrev.2016.03.018","doi":"https://doi.org/10.1016/j.autrev.2016.03.018","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.autrev.2016.03.018","pdf_url":null,"source":{"id":"https://openalex.org/S12874817","display_name":"Autoimmunity Reviews","issn_l":"1568-9972","issn":["1568-9972","1873-0183"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Autoimmunity Reviews","raw_type":"journal-article"},{"id":"pmid:27019051","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27019051","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Autoimmunity reviews","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":31,"referenced_works":["https://openalex.org/W187857992","https://openalex.org/W1481575941","https://openalex.org/W1532365878","https://openalex.org/W1543401110","https://openalex.org/W1634137532","https://openalex.org/W1865079657","https://openalex.org/W1975263472","https://openalex.org/W1979820418","https://openalex.org/W1998984179","https://openalex.org/W2010411786","https://openalex.org/W2024280428","https://openalex.org/W2030980006","https://openalex.org/W2061641422","https://openalex.org/W2066984389","https://openalex.org/W2068295318","https://openalex.org/W2071957388","https://openalex.org/W2084469556","https://openalex.org/W2088861734","https://openalex.org/W2093483949","https://openalex.org/W2094655231","https://openalex.org/W2108099607","https://openalex.org/W2111823261","https://openalex.org/W2111920377","https://openalex.org/W2146934536","https://openalex.org/W2157920732","https://openalex.org/W2188401913","https://openalex.org/W2193667868","https://openalex.org/W2282277504","https://openalex.org/W2317956278","https://openalex.org/W2527297869","https://openalex.org/W4248458980"],"related_works":["https://openalex.org/W3013409002","https://openalex.org/W3156454816","https://openalex.org/W3044438836","https://openalex.org/W2912386207","https://openalex.org/W3197847933","https://openalex.org/W2184374696","https://openalex.org/W2968277104","https://openalex.org/W2033215169","https://openalex.org/W2066862153","https://openalex.org/W2801405594"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":8},{"year":2018,"cited_by_count":9},{"year":2017,"cited_by_count":15},{"year":2016,"cited_by_count":4}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}